Unilife (NSDQ:UNIS) shares are up some 12% today after the medical device company announced its latest supply deal with a pharmaceutical major.
Novartis
Grifols acquires Novartis diagnostics unit for $1.7M
Former Abbott exec takes the helm at Creganna-Tactx Medical | Personnel Moves
Creganna-Tactx Medical CEO Helen Ryan is preparing to pass the torch after 8 years in the corner office, with Abbott (NYSE:ABT) executive Robert "Chip" Hance slated to take the helm in September.
Novartis employees flagged in Japanese data scandal | MassDevice.com On Call
MASSDEVICE ON CALL — Two former Novartis AG (NYSE:NVS) employees were involved in a massive data fabrication scandal surrounding the Kyoto Heart Study, a post-market trial examining the company’s Valsartan drug in more than 3,0000 patients.
ConforMIS lures Zimmer ops director to be its new operations SVP | Personnel Moves
ConforMIS lured Zimmer’s dental business operations director, Matthew Scott, away to be its new chief operating officer as it looks to scale up its customized knee implant business.
The Bedford, Mass.-based medical device company said Scott bring’s a decade’s worth of ops experience from his tenure at Zimmer. ConforMIS makes knee replacement implants and instrumentation that are custom-fit to patients’ morphology.
Feds probe Alcon in fraud case
The U.S. Dept. of Health & Human Services issued a subpoena to Novartis (NYSE:NVS) subsidiary Alcon Inc., seeking documents related to its marketing practices and payments to physicians.
The Sept. 23 subpoena is part of an HHS investigation probe into possible health care fraud, Novartis said in a regulatory filing.
Alcon loses bid to nix doc’s lens patent lawsuit
Novartis AG’s (NYSE:NVS) Alcon subsidiary lost its bid to throw out a lawsuit filed by a Florida ophthalmologist accusing it of infringing a patent for intraocular lens technology.
Dr. James Nielsen sued Alcon in December 2008, alleging that the Swiss medical device giant violated his patent for a “Multifocal Intraocular Lens.” Alcon moved to have Judge Janet Boyle of the U.S. District Court for Northern Texas toss a magistrate judge’s recommendation that she deny its motion to have the case dismissed.
Novartis promises 750 jobs in Fort Worth, Texas, if the city will cut 80% off its property taxes
Novartis AG’s (NYSE:NVS) recently acquired Alcon Inc. (NYSE:ACL) is wooing Fort Worth, Texas, legislators with promises of 750 new jobs with an average of $90,000 salary if the city can grant it an 80 percent break on its property taxes and waive some additional fees.
Alcon asked city officials to label its operations campus a "reinvestment zone" to grant it a 10 year property tax break worth about $490,000.
FDA approves expanded use for Abbott’s carotid stent | Regulatory roundup
Abbott Laboratories (NYSE:ABT) won aproval from the FDA for expanded use of its RX Acculink carotid stent system.
The expanded indication means the stent system can be used to treat carotid artery disease patients who have a standard risk for complications from carotid endarterectomy surgery, a procedure that entails cutting open a patient’s neck artery and scraping out blockages.
Alcon shareholders submit to Novartis
Alcon Inc. (NYSE:ACL) shareholders approved a final acquisition by Novartis AG (NYSE:NVS) at their annual meeting.
Under the terms of the takeover deal, Alcon shareholders will receive 2.9228 Novartis shares and a cash payment of $8.20 for each Alcon share, according to Alcon.
Based on NVS shares’ $55.60 latest closing price, the exchange represents a 1.4 percent premium over ACL shares’ closing price of $168.34 yesterday.
PerkinElmer buys out German molecular diagnostics firm | Acquisitions roundup
Here’s a roundup of companies announcing mergers, acquisitions and divestitures.